Lucid Diagnostics Inc. LUCD
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -52.26M | -45.01M | -58.01M | -53.29M | -55.26M |
| Total Depreciation and Amortization | 875.00K | 873.00K | 872.00K | 885.00K | 880.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.48M | 1.18M | 13.46M | 10.43M | 12.57M |
| Change in Net Operating Assets | -2.97M | -3.16M | -2.81M | -1.81M | -1.25M |
| Cash from Operations | -46.87M | -46.12M | -46.49M | -43.78M | -43.06M |
| Capital Expenditure | -315.00K | -319.00K | -197.00K | -405.00K | -377.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | -350.00K |
| Cash from Investing | -315.00K | -319.00K | -197.00K | -405.00K | -727.00K |
| Total Debt Issued | 0.00 | 0.00 | 360.00K | 21.98M | 21.98M |
| Total Debt Repaid | -- | -- | -- | -3.62M | -3.62M |
| Issuance of Common Stock | 49.48M | 49.10M | 58.67M | 58.67M | 31.63M |
| Repurchase of Common Stock | -17.00K | -17.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 49.47M | 49.08M | 59.03M | 77.03M | 49.99M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.28M | 2.64M | 12.35M | 32.84M | 6.20M |